JP3301100008
JP3301100008
KOBAYASHI PHARMACEUTICALS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 538.06B EUR | 403.44B EUR | 447.75B EUR |
Enterprise Value | 481.47B EUR | 357.13B EUR | 447.75B EUR |
Valuation Multiples | |||
Trailing P/E | 331.26x | -- | -- |
Forward P/E | 30.66x | -- | -- |
Price to Sales | 3.21x | -- | -- |
Price to Book | 2.57x | 1.92x | -- |
EV/Revenue | 2.88x | -- | -- |
EV/EBITDA | 24.62x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -2.35% | -- | -- |